Centro Médico Teknon
The total cost of cervical cancer treatment in Spain varies depending on the treatment plan. An initial consultation with an oncologist costs approximately $650. Preoperative examinations range from $370 to $530. Surgical treatments, such as a hysterectomy, can range between $19,650 and $27,300. Proton therapy is available for around $40,800 for 20 sessions. The treatment program is finalized after an individual assessment by a specialist.
| Turcja | Austria | Hiszpania | |
| Trachelektomia macicy | od $5,500 | od $14,500 | od $10,000 |
| Trachelektomia | od $2,500 | od $15,000 | od $12,000 |
| Tomoterapia | od $12,000 | od $30,000 | od $35,000 |
| Terapia promieniowaniem w raku szyjki macicy | od $4,000 | od $15,000 | od $10,000 |
| Radioterapia raka odbytnicy | od $7,000 | od $12,000 | od $10,000 |
HM Hospitales — to grupa 7 wiodących hiszpańskich klinik zlokalizowanych w Madrycie (Hiszpania).
Specjalizacja — onkologia dorosłych i dzieci, neurologia, neurochirurgia, kardiologia i ortopedia.
W 2018 roku 5 spośród 7 szpitali znalazło się w TOP najlepszych prywatnych klinik w Hiszpanii według Organizacji Monitorowania Reputacji Medycznej MERCO.
Corocznie chirurdzy HM wykonują ponad 26 000 operacji, a leczenie raka przechodzi tutaj około 2 500 pacjentów.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.
She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.
She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.
Główny badacz w badaniach klinicznych nad rakiem szyjki macicy — dr Oaknin kieruje badaniami nad angiogenezą i naprawą DNA w Hospital Quiron Barcelona.
Od ponad 20 lat specjalizuje się w onkologii dziecięcej — dr Lopez Ibor kieruje Oddziałem Hematologii i Onkologii Dziecięcej w szpitalu HM Montepríncipe.